Patients’ and clinicians’ attitude towards long-acting depot antipsychotics in subjects with a first episode of psychosis
Author:
Affiliation:
1. University Hospital of Psychiatry Zurich, Lenggstrasse 31, P.O. Box 1931, Zurich 8032, Switzerland
2. University Hospital of Psychiatry Zurich, Zurich, Switzerland
3. Institute of Psychiatry, King’s College London, London, UK
Abstract
Publisher
SAGE Publications
Subject
Pharmacology, Toxicology and Pharmaceutics (miscellaneous),Psychology (miscellaneous)
Link
http://journals.sagepub.com/doi/pdf/10.1177/2045125312464106
Reference48 articles.
1. Preventing the Second Episode: A Systematic Review and Meta-analysis of Psychosocial and Pharmacological Trials in First-Episode psychosis
2. The cost of relapse and the predictors of relapse in the treatment of schizophrenia
3. Evidence-based guidelines for the pharmacological treatment of schizophrenia: recommendations from the British Association for Psychopharmacology
4. Long Term Depot Antipsychotics
5. Antipsychotic long-acting injections: Prescribing practice in the UK
Cited by 55 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Schizophrenic patient’s preference for long-acting injectable antipsychotics in Saudi Arabia;Journal of Medicine and Health Studies;2024-06-30
2. Depot Versus Oral Antipsychotics in Patients with Schizophrenia: Which is Better on Side Effects, Functional Improvement, and Life Satisfaction;GAZI MED J;2024
3. Antipsychotic utilization, healthcare resource use and costs, and quality of care among fee-for-service Medicare beneficiaries with schizophrenia in the United States;Journal of Medical Economics;2023-04-06
4. The importance of early and proactive use of long-acting injectable antipsychotics in the management of schizophrenia;International Clinical Psychopharmacology;2023-03-06
5. The Effect of Longer Dosing Intervals for Long-Acting Injectable Antipsychotics on Outcomes in Schizophrenia;Neuropsychiatric Disease and Treatment;2023-03
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3